Skip to main content
RecallsAboutBlog

Sun Pharmaceutical Industries Inc

Sun Pharmaceutical Industries Inc: 12 recalls listed since January 2026 across FDA; 1 rated high risk.

By year

  • 202612

By agency

  • FDA12

By category

  • Drug12

All recalls (12)

Sun Pharmaceutical Industries Tretinoin Cream

Tretinoin Cream USP, 0.05% failed impurities and degradation specifications.

Low risk, FDA, , Drug impurity

Taro Nystatin Cream

Nystatin Cream, USP, failed stability specifications.

Moderate risk, FDA, , Quality testing problem

Taro Carbamazepine Tablets

Carbamazepine tablets may contain black specks from burnt excipient during manufacturing.

Moderate risk, FDA, , Quality problem

Sun Pharmaceutical Fexofenadine Hydrochloride Tablets

Fexofenadine Hydrochloride Tablets failed impurities and degradation specifications.

Low risk, FDA, , Drug impurity

Sun Pharmaceutical Perampanel CIII Tablets

Perampanel CIII Tablets, 6mg, may contain a 10mg tablet due to a label mix-up.

Moderate risk, FDA, , Labeling error

Sun Pharmaceutical Industries Budesonide Inhalation Suspension

Budesonide Inhalation Suspension contains black or brown specs and particles in the solution.

Moderate risk, FDA, , Foreign object

Forte BioPharma Xyvona (Levorphanol Tartrate Tablets)

Xyvona (levorphanol tartrate tablets) has a labeling issue and is not marketed under the proprietary name.

Moderate risk, FDA, , Labeling error

Sun Pharmaceutical Doxorubicin Hydrochloride Liposome Injection

DOXOrubin Hydrochloride Liposome injection contains glass particles that may cause irritation, swelling, blood vessel blockage, or life-threatening clots.

High risk, FDA, , Foreign object

Taro Fluocinonide Cream

Fluocinonide cream failed viscosity specifications.

Moderate risk, FDA, , Quality testing problem

Taro Diclofenac Sodium Topical Gel 3%

Diclofenac Sodium Topical Gel 3% has a viscosity that is slightly lower than the limit.

Moderate risk, FDA, , Quality testing problem

Sun Pharmaceutical Clindamycin Phosphate Topical Solution

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Low risk, FDA, , Drug impurity

Taro Pharmaceuticals Fluocinolone Acetonide Topical Solution

Fluocinolone Acetonide Solution Topical Solution failed impurity specifications due to an out-of-specification result for known impurity D.

Low risk, FDA, , Drug impurity
Embed this list